Xebio Co., Ltd. announced consolidated earnings results for the fourth quarter and year ended March 31, 2016. For the year, on consolidated basis, the company's net sales were JPY 221,391 million compared to JPY 210,672 million a quarter ago. Operating profit was JPY 6,167 million compared to JPY 5,654 million a quarter ago. Ordinary profit was JPY 6,394 million compared to JPY 6,432 million a quarter ago. Net profit was JPY 2,118 million compared to JPY 2,084 million a year ago. Net cash provided by operating activities was JPY 5,138 million compared to JPY 7,424 million a year ago. Capital expenditure was JPY 7,073 million compared to JPY 9,312 million a year ago.

For the quarter, on consolidated basis, the company reported net sales of JPY 54,375 million, operating profit of JPY 208 million, ordinary profit of JPY 249 million and net profit of JPY 1,240 million

For the fiscal year 2017, the company expects net sales of JPY 220,825 million, operating profit of JPY 5,888 million, ordinary profit of JPY 6,164 million and net profit of JPY 2,100 million.